Recombinant Thrombomodulin

Recombinant Thrombomodulin is a biopharmaceutical agent belonging to the class of anticoagulant proteins, distinguished by its engineered production through recombinant DNA technology to replicate the functional domains of human thrombomodulin for modulating coagulation and inflammation in disseminated intravascular coagulation.

296

Publications

14K

Citations

1.7K

Authors

472

Institutions

Publications per year

2017–2026

63

Variants

Art-123Thrombomodulin Alfa

Authors

1.7K

  1. IM
    Ikuro Maruyama

    Kagoshima University, Japan

    22 publications · 1.7K citations

    18

    h-index

  2. GH
    Goichi Honda

    Asahi Kasei (Japan), Japan

    14 publications · 574 citations

    13

    h-index

  3. CT
    Charles T. Esmon

    Oklahoma Medical Research Foundation, United States

    13 publications · 1.2K citations

    13

    h-index

  4. JM
    John Morser

    Stanford University, United States

    12 publications · 504 citations

    12

    h-index

  5. KG
    K Gomi

    Kagoshima University, Japan

    12 publications · 471 citations

    11

    h-index

1–5 of 1.7K

Venues

  1. Journal of Biological Chemistry

    JBC · 24 publications · 1.8K citations

    23

    h-index

  2. Thrombosis and Haemostasis

    19 publications · 864 citations

    16

    h-index

  3. Thrombosis Research

    13 publications · 371 citations

    12

    h-index

  4. Clinical and Applied Thrombosis/Hemostasis

    CATH · 7 publications · 166 citations

    7

    h-index

  5. Blood

    7 publications · 465 citations

    7

    h-index

1–5